Subscription Agreement for T1 [Shares] [Pre-Funded Warrants]Subscription Agreement • October 15th, 2024 • Inventiva S.A. • Pharmaceutical preparations
Inventiva S.A., a société anonyme organized under the laws of the French Republic, with a share capital of €524,771.88, consisting of 52,477,188 ordinary shares of €0.01 nominal value each (the “Ordinary Shares” and each, an “Ordinary Share”), and registered with the Commerce and Companies Registry of Dijon under the number 537 530 255 (the “Company”), is contemplating a transaction (the “Transaction”) that consists of:
AMENDMENT No 4 TO THE EXCLUSIVE LICENSE AND COLLABORATION AGREEMENTExclusive License and Collaboration Agreement • October 15th, 2024 • Inventiva S.A. • Pharmaceutical preparations
This FOURTH AMENDMENT TO THE EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT (this “Amendment #4”) is entered into as of October 11th, 2024 (the “Amendment #4 Effective Date”) by and between:
